Beijing Auto: BAIC Investment and Hyundai Motor invested US$ 1.095 billion in Beijing Hyundai. Beijing Auto announced that on December 11, 2024, BAIC Investment and Hyundai Motor entered into an agreement, and both parties agreed to jointly invest US$ 1.095 billion in Beijing Hyundai according to the proportion of their respective registered capital, and both parties invested US$ 548 million respectively. The capital injection will be carried out in stages. After the capital injection is completed, the registered capital of Beijing Hyundai will increase to US$ 4.074 billion, and Beijing Hyundai will still be owned by BAIC Investment and Hyundai Motor respectively, and will continue to be accounted for as a joint venture of the Company.Kremlin: It is very important to ensure the safety of our bases and diplomatic missions.Pakistan KSE-100 index rose 0.5% to 109,693.20.
Where to go: This year, the number of passengers who bought their first air ticket on the platform increased by 41% year-on-year. According to the data released by Qunar.com today, in 2024, the number of passengers who bought their first air ticket increased by 41% year-on-year, with the highest growth rate in Shanghai, Beijing, Yunnan, Fujian and Hubei. The number of residents in cities below the third tier where they bought their first air ticket increased by 35% year-on-year, a record high of nearly five years. From the perspective of age structure, young people under the age of 18 have become the main group where to buy their first air ticket, with a year-on-year increase of over 50%. Students aged 19-23 and young people aged 24-33 are the main growth forces. At the same time, the platform data shows that the number of passengers who left the country by plane for the first time in 2024 increased by 220% year-on-year, and the number of residents in third-tier cities and below who left the country by plane for the first time increased by 2.5 times. The most popular destinations for first-time outbound travel are Hongkong, China, Bangkok, Thailand and Kuala Lumpur.R&F Properties announced on the Hong Kong Stock Exchange that the High Court ordered that the hearing of R&F Hong Kong's petition be postponed until December 16, 2024.Market News: US Secretary of State Blinken will travel to Jordan and Turkey for talks on the Syrian issue on Wednesday.
It is reported that the Bank of Japan thinks that it is no harm to raise interest rates later, but it does not rule out taking action in December. On December 11th, according to informed sources, officials of the Bank of Japan believe that it is not costly to raise interest rates later, and they are still open to taking action next week, depending on data and market trends. The authorities believe that even if the Bank of Japan decides to wait until January or later, it will not pay a huge price, because there are signs that there is little risk that inflation may exceed the target. They also said that if the December meeting proposed to raise interest rates, some officials would not object. According to people familiar with the matter, officials think it is only a matter of time to raise interest rates again, because the economy and inflation are in line with their forecasts. Before announcing the policy decision on December 19, officials will carefully evaluate the data and financial markets before making a final decision.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)MONDELEZ's share price rose 2.5% before the market, and it was authorized to buy back $9 billion in the news.
Strategy guide
12-13
Strategy guide